首页|期刊导航|中国老年保健医学|增强型体外反搏联合运动处方在冠心病PCI术后合并心力衰竭的疗效分析

增强型体外反搏联合运动处方在冠心病PCI术后合并心力衰竭的疗效分析OA

Effectiveness analysis of enhanced external counterpulsation combined with exercise prescription in heart failure patients after percutaneous coronary intervention for coronary artery disease

中文摘要英文摘要

目的 探讨增强型体外反搏(Enhanced external counterpulsation,EECP)联合运动处方对冠状动脉粥样硬化性心脏病(简称冠心病)患者行经皮冠脉介入治疗术(Percutaneous coronary intervention,PCI)后合并心力衰竭的治疗效果.方法 选择广西壮族自治区江滨医院2021 年8 月至2023 年12 月收治的100 例冠心病 PCI 术后合并心力衰竭的患者,根据患者治疗方案不同进行分配,研究组(规范药物治疗+运动处方+EECP 治疗)和对照组(规范药物治疗+运动处方),每组50 例.观察两组患者治疗前、治疗3 个月后的6 分钟步行试验(6-minute walking test,6MWT)、N 末端脑钠肽前体(n-ter-minal pro-brain natriuretic peptide,NT-pro BNP)、左心室射血分数(left ventricular ejection fraction,LVEF)、左心室舒张末径(left ventricular end-diastolic dimension,LVEDD)、左心室收缩末期内径(left ventricular end-systolic diameter,LVESD)、无氧阈值(anaerobic threshold,AT)、心功能级别提高有效率、心力衰竭再住院、心绞痛再发、心肌梗死再发发生率.结果 研究组治疗总有效率达98.00%(49/50),明显高于对照组的 84.00%(42/50),组间差异有统计学意义(χ2=4.396,P=0.036).研究组治疗3 个月后6MWT、LVEF、AT 大于对照组,差异有统计学意义(P<0.05),另外 LVEDD、LVESD、NT-pro BNP 小于对照组,差异有统计学意义(P<0.05).研究组心力衰竭再住院、心绞痛再发、心肌梗死再发发生率为 10.00%(5/50),低于对照组[32.00%(16/50)],组间比较差异有统计学意义(χ2=7.294,P=0.007).结论 EECP 联合运动处方改善冠心病PCI 术后合并心力衰竭患者的6 分钟步行距离、运动耐量及心力衰竭等相关指标效果明显,对改善近期疗效及远期预后有一定意义.

Objective To explore the clinical efficacy of enhanced external counterpulsation(EECP)combined with exercise pre-scription in treating patients with coronary artery disease complicated with heart failure after percutaneous coronary intervention(PCI).Methods A total of 100 patients diagnosed with coronary artery disease and post-PCI heart failure who received treatment in Jiangbin Hospital of Guangxi Zhuang Autonomous Region from August 2021 to December 2023 were enrolled and equally random-ized into two groups(50 cases in each group).The control group received standard drug therapy combined with exercise prescription,while the study group was additionally treated with EECP on the basis of the control group regimen.All patients were evaluated before treatment and three months after intervention.Observation indicators included the 6-minute walking test(6MWT),N-terminal pro-brain natriuretic peptide(NT-proBNP),left ventricular ejection fraction(LVEF),left ventricular end-diastolic dimension(LVEDD),left ventricular end-systolic dimension(LVESD),and anaerobic threshold(AT).The clinical efficacy rate of cardiac function im-provement and the incidences of heart failure rehospitalization,angina recurrence and myocardial infarction recurrence were statisti-cally compared.Results The total clinical effective rate was 98.00%(49/50)in the study group,which was significantly higher than 84.00%(42/50)in the control group(χ2=4.396,P=0.036).After treatment,the study group exhibited significantly higher levels of 6MWT,LVEF and AT,as well as lower levels of LVEDD,LVESD and NT-proBNP(all P<0.05).The total incidence of ad-verse clinical events(heart failure rehospitalization,recurrent angina and recurrent myocardial infarction)in the study group was 10.00%(5/50),which was markedly lower than 32.00%(16/50)in the control group(χ2=7.294,P=0.007).Conclusion EE-CP combined with exercise prescription can significantly improve walking ability,exercise tolerance and cardiac function indicators in post-PCI patients with coronary artery disease and heart failure.This combined regimen presents superior clinical efficacy and helps optimize both short-term and long-term patient prognosis,which is worthy of clinical promotion.

农克继;张树锋;曾晓聪

广西医科大学第一附属医院心血管内科 530021||广西壮族自治区江滨医院心血管内科 530021广西壮族自治区江滨医院心血管内科 530021广西医科大学第一附属医院心血管内科 530021

增强型体外反搏心力衰竭冠心病经皮冠脉介入治疗术后

enhanced external counterpulsationheart failurecoronary artery diseasepost-percutaneous coronary intervention

《中国老年保健医学》 2026 (4)

12-15,4

广西壮族自治区卫生健康委员会自筹经费科研课题(编号:Z20210946)

10.3969/j.issn.1672-2671.2026.04.002

评论